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Thepathogenesis ofvasculitis associated with an-
ti-neutrophil cytoplasmic antibodies is not estab-
lished. The anti-neutrophil cytoplasmic antibody
autoantigens proteinase 3 (PR3) and elastase in-
duce detachment and cytolysis of endothelial cells
in vitro. We investigated whetherPR3 and elastase
trigger endothell ceUl apoptosis. Primary bovine
pulmonary artery endothelial cells were treated
with either PR3, elastase, or myeloperoxidase
(MPO) and apoptosis assessed by four different
methods. By the cel death detection enzyme-linked
immunosorbent assay, DNA fragmentation in-
creased to 208 ± 84% or 153 ± 27% ofcontrol with
I pg/ml PR3 or elastase at 24 hours. By ultraviolet
light microscopy, thepercentage ofapoptotic cells
significantly increased (P < 0.05) with 5 or 10
pg/mlPR3 and 25 or50 pg/nl elastase at 6, 12, or
24 hours. Values at the 24-hour time point are
15.3 ± 6.4% or 25.8 + 6.6%for 5 or 10pg/ml PR3
and 13.9 + 3.6% or 20.7 ± 1.8%for 25 or 50 pg/ml
elastase compared with 2.2 ± 1.2% for control.
Similarly, withflow cytometry, 5 or 10 pg/ml PR3
and 25 or 50 pg/ml elastasefor 6, 12, or 24 hours
demonstrated increasing apoptosis in a dose- and
time-dependent manner with the highest values
achieved at 24 hours (23.4 ± 4.0% and 35.6%for5
and 10 pg/milPR3 and31.8 + 4.0% and 478%ofor25
and50 pg/ml elastase compared with 7.9 ± 2.2% in
control). Typical DNA laddering was apparent
from 6 to 24 hours at5 or 10 pg/ml PR3 and 25 or
50 pg/ml elastase. Myeloperoxidase did not induce
cell apoptosis. Release ofPR3 and elastase by ac-
tivated neutrophils during acute inflammation, in-
cluding anti-neutrophil cytoplasmic antibody-
associated vasculitis, may result in vascular dam-
age by endothelial ceUl apoptosis. (Am J Pathol
1996 149:1617-1626)
Anti-neutrophil cytoplasmic antibodies (ANCA) di-
rected against granule proteins of neutrophils and
monocytes are associated with crescentic glomeru-
lonephritis and systemic necrotizing vasculitis, in-
cluding Wegener's granulomatosis, microscopic
polyangiitis, and Churg-Strauss syndrome.1`5 The
two major subtypes of ANCA that can be distin-
guished by indirect immunofluorescence assay are
C-ANCA that produce a cytoplasmic staining pattern
and P-ANCA that produce a perinuclear staining
pattern of alcohol-fixed neutrophils.3 In patients with
vasculitis, the major specificity for P-ANCA is myelo-
peroxidase (MPO), and minor specificities, such as
elastase, cathepsin G, and other granule proteins,
have been described.3-5 The major specificity for
C-ANCA is proteinase 3 (PR3).5-
The pathogenesis of ANCA-associated diseases
has not been established. Neutrophil activation and
endothelial cell damage have been suggested to be
involved in ANCA-associated vascular injury. Sev-
eral mechanisms of neutrophil-mediated endothelial
damage have been described.`10 After the activa-
tion and degranulation of polymorphonuclear leuko-
cytes, azurophilic granule proteins such as MPO,
PR3, elastase, and cathepsin G are released. Serine
proteases PR3 and elastase have been shown to
induce direct detachment and cytolysis of endothe-
lial cells in vitro.11-13 PR3 and elastase are also ca-
pable of inducing emphysematous lesions upon in-
tratracheal instillation in vivo. 14
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Granzymes, which are serine proteases from
granules of cytotoxic T lymphocytes and natural killer
cells to which PR3 and elastase share sequence
homology and serine protease activity,15'16 are ca-
pable of inducing apoptosis in different target
cells.16-20 Recent studies have provided evidence
that some intracellular serine proteases and a se-
creted serine protease from an epidermal keratino-
cyte cell line Pam212 induce apoptosis in several
target cell lines.2'22
The aim of this study was to investigate whether
neutrophil serine proteases, PR3 or elastase, could
induce endothelial cell apoptosis in vitro.
Materials and Methods
Granule Protein Preparation
Human polymorphonuclear leukocytes were obtained
from leukemic human donors23 and stored at -700C in
Hanks' balanced salt solution containing 0.75 mmol/L
phenylmethylsulfonyl fluoride (PMSF; Sigma Chemical
Co., St. Louis, MO), 0.1 mmol/L leupeptin (Sigma), and
10 gg/ml aprotinin (Sigma) until use.24 Upon thawing,
neutrophils were resuspended in cavitation buffer with
1 mmol/L PMSF and cavitated at 350 psi for 20 minutes
at 40C. The cavitate containing 1.25 mmol/L EGTA was
centrifuged for 10 minutes at 1400 x g, and the result-
ing supernatant was centrifuged for 20 minutes at
8700 x g.24'25 The pellet containing the granule frac-
tion was extracted in 0.2 mol/L sodium acetate buffer,
pH 4.0, containing 10 mmol/L calcium chloride and 1
mmol/L PMSF, sonicated, and then centrifuged at
100,000 x g for 1 hour at 4°C. The supernatant fluid
contained granule proteins.23
Isolation of MPO, Elastase, and PR3
The granule proteins were chromatographed on a
fast protein liquid chromatography (FPLG) mono S
cation exchange column, HR 5/5 (Pharmacia, Upp-
sala, Sweden). Bound proteins were eluted with a
gradient from 0.15 to 2.0 mol/L NaCI in 0.05 mol/L
sodium acetate buffer, pH 4.0 at a flow rate of 1
ml/minute. The peaks between 0.6 and 0.8 mol/L
NaCI contained MPO and elastase as determined by
anti-MPO and anti-elastase enzyme-linked immu-
nosorbent assay (ELISA). The combined and con-
centrated fractions of these peaks, 2 ml, were ap-
plied to a FPLC Superose 12 gel filtration column, HR
16/50 (Pharmacia). Protein was eluted with 0.05
mol/L sodium acetate buffer, pH 5.0, at a flow rate of
0.5 ml/minute and resulted in only two major peaks.
The peak having a molecular weight of approxi-
mately 140 kd was identified as MPO by enzymatic
activity and by ELISA. The next peak of 29 kd was
elastase as determined by ELISA.
Fractions eluting of the mono S column from 1.1 to
2.0 mol/L NaCI contained PR3 as identified by anti-
PR3 ELISA. These fractions were collected, concen-
trated, dialyzed against 0.02 mol/L potassium phos-
phate buffer, pH 6.5, starting buffer, and applied to a
monoclonal anti-PR3 affinity column that was equili-
brated with starting buffer. The affinity column was
washed with 0.2 mol/L NaCI in 0.02 mol/L potassium
phosphate buffer, and bound proteins were eluted
as a single peak with 0.02 mol/L glycine/HCI buffer,
pH 2.75. The eluted peak was immediately adjusted
to pH 6.5 with 1 mol/L Tris/HCI, pH 9.0, and stored in
aliquots at -700C.
The purity of MPO, elastase, and PR3 was docu-
mented using amino acid sequencing, monoclonal
and polyclonal antibody ELISA, sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-
PAGE), Western blot, and enzymatic activity. MPO
isolated by our laboratory had an optical density
A430/A280 ratio of 0.73, enzymatic activity of 172
U/mg protein using 4-aminoanipyrine as a sub-
strate,26 produced one band of approximately 140
kd on SDS-gel electrophoresis and Western blot,
and reacted with monoclonal mouse and polyclonal
rabbit anti-human MPO (Dako, Carpinteria, CA) by
ELISA. Isolated elastase had enzymatic activity us-
ing N-Succinyl-(Ala)3-p-Nitroanilide as substrate,27
produced one 29-kd band on SDS-PAGE and West-
ern blot, reacted with monoclonal mouse anti-human
elastase (Chemicon, Temecula, CA) and sheep anti-
human elastase (The Binding Site, Birmingham, UK)
by ELISA, and showed the first 20 amino-terminal
amino acid sequence to be IVGGRRARPHAWPFM-
VSLQL. Isolated PR3 had enzymatic activity using
N-t-Boc-Alanine-p-Nitrophenyl ester as substrate,28
produced one 29-kd band on SDS-PAGE and West-
ern blot, by ELISA reacted with monoclonal mouse
and polyclonal rabbit anti-human PR3 isolated by our
laboratory, and showed the first 16 amino-terminal
amino acid sequence to be IVGGHEAQPHSRPYMA.
Thus, although neutrophils from a leukemic patient
were used as the source of protein, there was no
variance detected by any of these methods as com-
pared with protein from healthy donor neutrophils.
The cross-contamination between granule proteins
was excluded based on reactivity with specific
monoclonal and/or polyclonal antibodies by ELISA.
In addition, no protein preparations contained de-
tectable endotoxin (<0.09 EU/mI) as measured by
the limulus amebocyte lysate assay system, Pyro-
gent (BioWhittaker, Walkersville, MD).
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Cell Culture
Primary bovine pulmonary arterial endothelial cells
were purchased from the American Type Culture
Collection (CCL 209, Rockville, MD) and grown in
minimal essential medium supplemented with 20%
fetal calf serum, 100 U/ml penicillin, and 100 jig/ml
streptomycin. The cultures were maintained in a hu-
midified tissue culture incubator at 370C in an atmo-
sphere of 5% C02/95% air.
Endothelial cells, used between the third and sixth
subcultivation and during log phase growth, were
seeded in 25-cm2 cell culture flasks (Costar Corp.,
Cambridge, MA), at 2 x 106 cells in 8 ml of media
per flask or in 48-well cell culture plates (Costar) at a
density of 5 x 104 cells in 0.5 ml of medium per well
and grown to confluence over 24 hours. Cells were
treated with either 0.1 to 10 ,tg/ml PR3, 0.1 to 50
gtg/ml elastase, or 0.1 to 50 gg/ml MPO for 6, 12, and
24 hours. Medium containing 20 ng/ml tumor necro-
sis factor (TNF) and 3 ,tg/ml cycloheximide for 4
hours served as a positive control29 and medium
containing either phosphate-buffered saline (PBS),
appropriate elution buffer, or protease inhibitors, in-
cluding PMSF, leupeptin, and aprotinin, served as
negative controls.
For all assays, both detached and adhered cells
were harvested and combined before being as-
sayed.
Apoptosis Detection Assays
Quantification of DNA Fragmentation by ELISA
DNA fragmentation was measured by the cell
death detection ELISA kit (Boehringer Mannheim,
Mannheim, Germany). This kit detects histone-asso-
ciated DNA fragments and uses monoclonal anti-
histone antibody as the coating solution, DNA frag-
ments from cell lysate (0.5 x 104 cells) as the sample
solution, and monoclonal anti-DNA-peroxidase as
the conjugate solution. The optical density was read
at 405 nm, and results were expressed as the per-
centage of control.
Measurement of Apoptotic Cells by Ultraviolet
(UV) Light Microscopy
Cells were cytocentrifuged, fixed in ethanol, air
dried, and stained with DNA-specific dyes including
either 1 ,tg/ml 4',6-diamidino-2-phenylindole (Sig-
ma) and 20 ,ug/ml sulforhodamine 101 (Fisher, Pitts-
burgh, PA) for 10 minutes, 20 ,tg/ml propidium io-
dide (Sigma) for 30 minutes, or 3 ,tg/ml acridine
orange (Sigma) for 3 hours.30 32 Cellular morphol-
ogy was assessed using a Nikon FXA research light
microscope (Nikon, Garden City, NY). Apoptotic
cells were identified by chromatin condensation and
fragmentation.29'30 At least 500 cells from randomly
selected fields were counted. Data reported repre-
sent the mean + SD of triplicate samples from at
least two independent experiments.
Detection of DNA Content by Flow Cytometry
Cell cycle progression and cell death were moni-
tored by measuring the population distribution of
DNA content.2930 Cells (2.5 x 106) were fixed in
ethanol/PBS (70% v:v, 4°C) and resuspended in pro-
pidium iodide staining mixture (50 ,ug/ml propidium
iodide in PBS plus 0.125 mmol/L EDTA, 0.25% bo-
vine serum albumin, and 150 ,tg/ml RNAse (Sigma)).
After 2 hours of incubation at 40C in the dark, DNA
content was determined with a FACScan flow cytom-
eter (Becton Dickinson Immunocytometry Systems,
San Jose, CA) linked to a Cicero/Cyclops system
(Cytomation, Fort Collins, CO) for data acquisition
and analysis. At least 20,000 cells were analyzed in
each sample. Ethanol fixation caused an increase of
cell permeability allowing low molecular weight DNA
fragments to leak out of cells. Thus, apoptotic cells
were identified by a decrease in DNA content and
formed the apoptotic sub-GO/Gl population peak to
the left of the GO/G1 peak.
Analysis of DNA Fragmentation by Gel
Electrophoresis
Cells (2.5 x 106) were resuspended in 0.5 ml of lysis
buffer (0.5 mmol/L Tris/HCI, pH 7.5, 20 mmol/L EDTA,
pH 8.0, 0.5% Triton X-100) and incubated at 40C for 30
minutes. Lysate was centrifuged at 20,000 x g at 40C
for 20 minutes, and supernatant was extracted with
equal volumes of Tris-saturated phenol pH 7.4/chloro-
form/isoamyl alcohol (25:24:1) and re-extracted with
chloroform/isoamyl alcohol (24:1). DNA was precipi-
tated overnight with 2.2 vol of ethanol in the presence
of 0.3 mol/L sodium acetate, pH 5.2, and centrifuged at
13,500 x g at 40C for 15 minutes. The pellet was
resuspended in 15 ml of Tris/EDTA plus RNAse A, and
the concentration was determined by UV absorbance
at 260 nm. The same amount of nucleic acid from each
sample was subjected to electrophoresis on 1.5% aga-
rose gels containing ethidium bromide (0.5 ,ug/ml).
DNA was visualized under UV transillumination and
photographed.33
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Figure 1. DNAfragmentation ofendothelial cell by ELISA. Cells (5 x 104 cells/uvell) were cultured in 48-wellplates. DNAfragmentation nas measured
by cell death detection ELISA kit, and results were expressed as percent change of control. A: Concentration dependency. Cells uwere treated uwith the
indicated concentrations ofPR3, elastase (HNE), orMPOfor 24 hours. B: Time dependency. Cells were treated with 1 p.g/ml PR3, HNE, or MPOfor
the indicated times. *Statisticallv differentfrom MPO (P < 0.0255). Bars, means + SEM.
Statistical Analysis
Wilcoxon rank sum tests were used to compare
percent change of control for PR3 and elastase
groups with the MPO group at different doses and
incubation times. PR3 and elastase groups were
not compared with each other. A P value of 0.025
or less was set as statistically significant for this
analysis (0.05/2).
The percentage of apoptotic cells at different
doses and incubation times was also compared with
controls using Wilcoxon rank sum tests. Differences
between MPO, PR3, and elastase for each of these
measures were not evaluated, and comparisons be-
tween doses response and time course within MPO,
PR3, and elastase were not measured. As multiple
statistical tests were performed to compare all doses
and incubation times with the controls, a P value of
less than or equal to 0.007 was considered statisti-
cally significant for the evaluation of the percentage
of apoptotic cells. This P value was calculated by
dividing 0.05 by the maximal number of tests per-
formed (n = 7) within the evaluation of dose or incu-
bation times (0.05/7 0.007). Other P values be-
tween 0.05 and 0.008 were considered to be
borderline statistically significant.
Results
DNA Fragmentation by ELISA
By ELISA, DNA fragmentation of endothelial cells
treated with PR3 or elastase was increased in a dose-
and time-dependent manner (Figure 1). DNA fragmen-
tation was 1073 + 1523% of control with TNF and
cycloheximide treatment. With PR3 treatment, DNA
fragmentation started to increase at 0.2 gg/ml PR3 and
progressed to 406 ± 31% of control with 10,ug/ml PR3
for 24 hours of treatment, which represents more than
a fourfold increase compared with control. With elas-
tase treatment, DNA fragmentation started to increase
at 1 ,ug/ml and reached 319 + 76% of control with 25
,ug/ml elastase for 24 hours of treatment, which repre-
sents more than a threefold increase compared with
control. However, cells treated with MPO did not dem-
onstrate an increase in the DNA fragmentation, and the
maximal value was only 127% in cells treated with 25
jig/ml MPO for 24 hours.
Apoptotic Cells by UV Light Microscopy
By UV light microscopy using DNA-specific dyes,
PR3 and elastase caused a dose- and time-depen-
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Figure 2. UVfluorescence photomicrographs ofendothelial cells stained by DAPI. A: Untreated cells shouw uniform nuclei with bluefluorescence. B:
Cells treated uwith 10 p.gnml PR3 for 24 hours depict typical apoptotic morphology with nuclear fragymentation and homogeneous DNA staining in
granules of dif/rent sizes. Magnification, X375.
dent increase in the number of cells with chromatin
condensation and fragmentation (Figures 2 and 3).
Observation of untreated cells by UV light micros-
copy revealed uniform nuclei and intact plasma
membranes as shown by fluorescence dye staining
(Figure 2A). PR3- and elastase-treated cells had
fragmented nuclei of different sizes strongly stain-
able with DNA-specific dyes, which is characteristic
of apoptosis (Figure 2B). The proportion of apoptotic
cells was 2.2 + 1.2% in untreated endothelial cells
and 63.8 + 25.9% in positive control cells treated
with TNF and cycloheximide. With PR3 treatment, the
morphological evidence of increased apoptosis was
first apparent with 1 ,ug/ml PR3, and the percentage
of apoptotic cells reached 25.8 ± 6.6% in cells
treated with 10 gg/ml PR3 for 24 hours. With elastase
treatment, the percentage of apoptotic cells started
to increase with 10 ,ug/ml elastase and reached
20.7 + 1.8% in cells treated with 50 ,ug/ml elastase
for 24 hours. Compared with control, the changes
are statistically significant with both 5 or 10 ,ug/ml
PR3 and 25 or 50 ,ug/ml elastase treatment for 6 to 24
hours, whereas treatment with 1 to 50 jig/ml MPO for
6 to 24 hours did not cause an increase in apoptosis
(Figure 3, A and B).
DNA Content by Flow Cytometry
By flow cytometry, PR3 and elastase induced a
dose- and time-dependent increase in the number of
cells containing degraded DNA (Figure 4). DNA con-
tent in cells treated with PR3 and elastase was less
than that of untreated cells after ethanol fixation and
formed a sub-GO/Gl peak, which is characteristic of
apoptosis (Figure 4, A and B). The proportion of
apoptotic cells was 7.9 ± 2.2% in untreated endo-
thelial cells and 69.7 ± 14.4% in TNF- and cyclohex-
imide-treated positive control cells. With PR3 treat-
ment, an increase in the number of cells containing
degraded DNA was first apparent with 1 ,ug/ml PR3.
The percentage of apoptotic cells increased to
16.8 ± 3.0% for 12 hours and 23.4 ± 4.0% for 24
hours with 5 ,ug/ml PR3 treatment and reached a
maximal value of 35.6% with 10 gg/ml PR3 treatment
for 24 hours. With elastase treatment, an increase in
the number of apoptotic cells was first apparent with
10 ,ug/ml elastase. The percentage of apoptotic cells
increased to 26.9 + 3.5% for 12 hours and 31.8 +
4.0% for 24 hours with 25 ,ug/ml elastase treatment
and reached a maximal value of 47.8% with 50,ug/ml
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Figure 3. Percentage ofapoptotic endothelial cells by Uvlight microscopy. Cells were cultured in 25-mm2flasks, and theproportion ofcells undergoing
apoptosis was determined by cell counts using, fluorescence microscopy withfluorescent dyes. A: Concentration dependency. Cells were treated with
the indicated concentrations ofPR3, elastase (HNF), orMPOfor 24 hours. B: Time dependency. Cells were trceated with 5 luglml PR3, 25 uglml HNL,,
or 50 ,glml MPOJbr the indicated times. '+Statistically differentfrom control ( P ' 0.007; + 0.007 < 1P < 0.05). Values are means - SEM;, n = 6,
+n= 4.
elastase treatment for 24 hours. Compared with con-
trol, the changes are statistically significant with both
5 or 10 ,ug/ml PR3 and 25 or 50 ,ug/ml elastase
treatment for 6 to 24 hours, whereas treatment with 1
to 50 ,tg/ml MPO for 6 to 24 hours did not cause an
increase of apoptosis (Figure 4C).
Nuclear Fragmentation by Gel
Electrophoresis
By agarose gel electrophoresis analysis, DNA
from endothelial cells treated with PR3 and elas-
tase revealed an internucleosomal cleavage pat-
tern, as evidenced by DNA fragments equivalent
to approximately 200 bp and their multiples, char-
acteristic of apoptotic cell death. Typical DNA lad-
dering was present in cells treated with 5 or 10
,ug/ml PR3 or 25 or 50 ,tg/ml elastase from 6 to 24
hours and in positive control cells treated with TNF
and cycloheximide. In MPO-treated cells, even
with doses up to 50 ,tg/ml, no DNA laddering was
apparent (Figure 5).
Discussion
Neutrophil-mediated endothelial injury is believed to
play an important role in the pathophysiology of
ANCA-associated vasculitis. This is supported by a
number of studies in which ANCA induce neutrophil
activation that releases oxygen radicals and other
toxins, such as proteases, cationic proteins, and
collagenases causing endothelial cell damage.34
Furthermore, co-incubation of freshly isolated un-
stimulated neutrophils with cytokine-activated endo-
thelial cells results in endothelial injury. Under these
assay conditions, serine protease inhibitors mark-
edly diminish endothelial cell injury. Purified human
neutrophil elastase mimics the effect of the neutro-
phils to induce endothelial injury.11
Recently, several studies have evaluated the di-
rect cytotoxicity of serine proteases PR3, elastase,
and cathepsin G. In vivo, rat renal perfusion of micro-
gram quantities of active elastase or cathepsin G
results in severe proteinuria,35 and intratracheal in-
stillation of approximately 0.1 mg of PR3 or elastase
causes emphysema in hamsters or dogs.14,36,37 Fur-
thermore, recent data demonstrate that PR3 and
elastase are localized extracellularly in renal tissue in
patients with Wegener's granulomatosis and ANCA-
associated rapidly progressive glomerulonephritis,
suggesting that release of these proteases contrib-
ute to tissue injury.38'39 In vitro, detachment and cy-
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Figure 4. DNA content ofendothelial cells byflow cytometry. DNA distributions were obtained after endothelial cell staining with PI. Cells containing
degraded DNA representing apoptotic cells are located to the left of the Cl peak. A: In cells treated with 0 to 10 gglml PR3 for 24 hours, apoptotic
peaks were observed uith 5 or 10 vtglnl PR3. B: In cells trceated uith 0 to 50 pglml elastase (HNE) for 24 houts, apoptotic peaks u'ere observed with
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Figure 5. DNA size agarose gel analysis. Fragmented DNA was ex-
tracted and sub]ected to electrophoresis in 1.500 ag-'arose gels. DNA
molecular Uweight markers are shown in lane 1. DNA from untreated
cells are in lane 2. Cells treated with 20 niglml TNF and 3 ixg/ml
cvcloheximide for 4 hours, serve as a positive, countrol (lane 3). DNA
fragmentationi from cells treated u'ith 1, -5, or 10 ,.Lg/ml PR3 (lanes 4
to 6); 1, 5, 25, or 50 .gg/ml elastase (HNEL lanes 7 to 10); or 1, 5, 25,
or 50 p.g/ml MPO (lanes 1 1 to 14) for 24 hours are shown. Tyvpical
DNA laddering is~present in cells treated u'ith 5 or jiLg/ml PR3 or 25
or 50 j.tglml HNE, but not MPO.
by purified PR3 and elastase have been investigat-
ed.11-13 incubation of confluent monolayers of
HUVECs with 100 mU/mI PR3 for 3 hours resulted in
20% detachment and 30% cytolysis and with 350
mU/mI elastase induced 40% detachment and 15%
cytolysis without serum.13
We investigated direct cytotoxicity of PR3, elas-
tase, and MPO in cultured bovine pulmonary arterial
endothelial cells. Our data demonstrate that PR3 and
elastase trigger cultured endothelial cell apoptosis.
This is supported by the results that 1) the DNA
fragmentation of endothelial cells treated with PR3 or
elastase is significantly increased as detected by
ELISA, 2) the proportion of endothelial cells contain-
ing condensed chromatin and fragmented nuclei
was statistically increased with PR3 or elastase treat-
ment as measured by cell counts using UV light
microscopy after DNA-specific fluorescent dye stain-
ing, 3) DNA content of endothelial cells treated with
PR3 or elastase decreased to form a sub-GO/Gl
peak as determined by flow cytometry, and 4) an
internucleosomal DNA cleavage pattern was ob-
tained from endothelial cells treated with PR3 and
elastase as analyzed by gel electrophoresis.
The mechanism of endothelial cell apoptosis trig-
gered by PR3 and elastase remains unclear. The
possible roles of proteases in apoptosis are numer-
ous and include activation of endogenous endonu-
clease, degradation of extracellular matrix compo-
nents, increase in membrane permeability, a direct
effect on cell mitosis, activation of a receptor, or
stimulation of the target cells to take up other factors
that cause apoptosis or degradation of other factors
that inhibit apoptosis and so on.16'20'22 In this study,
apoptotic endothelial cells are no longer adherent to
the flask. The percentage of apoptotic cells are pro-
portional to the degree of cell detachment (data not
shown), indicating that detachment of endothelial
cells from the matrix correlates with the apoptosis
induced by PR3 and elastase. A series of studies has
already demonstrated that endothelial cells must be
adherent to extracellular matrix proteins to survive
and proliferate.40 42 Failure to adhere to a substra-
tum may affect cell metabolism, including DNA syn-
thesis and transcription, and stretch-activated ion
channels in the plasma membrane, which represents
a signal to activate a suicide process in these
cells.42 When adhesion is prevented, endothelial
cells rapidly undergo cell death with the morpholog-
ical and biochemical characteristics of apopto-
sis.40-42 The role of neutrophil PR3 and elastase
in the detachment of HUVECs has been de-
scribed.11-13 PR3, elastase, and cathepsin G are
capable of degrading several constituents of the
glomerular basement membrane, including fibronec-
tin, laminin, and collagen type IV and heparan sulfate
proteoglycans of subendothelial matrix to cause de-
tachment of glomerular endothelial cells and glomer-
ular injury.14'28'43-45 Whether apoptosis causes de-
tachment or detachment triggers apoptosis by PR3
and elastase is not confirmed in these studies but is
the focus of ongoing investigations.
It remains to be determined whether proteolytic
activity is necessary for PR3 and elastase to cause
apoptosis of endothelial cells. A number of studies
have demonstrated that serine protease activity is
required for cellular cytotoxicity, especially serine
proteases derived from cytotoxic T lymphocytes and
natural killer cells.16'21'22 PR3- and elastase-medi-
ated endothelial detachment and cytolysis are inhib-
ited by al-proteinase inhibitor, whereas only elas-
tase-mediated but not PR3-mediated detachment
and cytolysis is inhibited by anti-leukoprotease.13 In
contrast, both enzymatically active and inactive PR3
enhances interleukin-8 production by HUVECs, yet
only enzymatically active elastase enhances inter-
leukin-8 production.46 In our study, PR3 and elastase
have low enzymatic activity as they were isolated in
the presence of the protease inhibitors PMSF, leu-
peptin, and aprotinin and were incubated with 20%
fetal calf serum that contains the protease inhibitor
al -anti-trypsin.
In our study, PR3 and elastase, but not MPO,
induced endothelial cell apoptosis in a dose- and
time-dependent manner. Release of PR3 and elas-
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tase by activated neutrophils and monocytes during
any type of acute inflammation, including ANCA-
associated vasculitis, may result in vascular damage
by endothelial cell apoptosis. In other words, endo-
thelial cell apoptosis induced by PR3 and elastase
may be a very important mechanism of injury in all
forms of acute inflammation in which neutrophils and
monocytes are activated.
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